Evidence map›Paper›PMID 34873457›Full record

ReviewAmerican journal of cancer research2021

New insights into the functions of progesterone receptor (PR) isoforms and progesterone signaling.

Juberiya M Azeez, Thachapillil Ramakrishnan Susmi, Viji Remadevi, Vini Ravindran, Anjana Sasikumar Sujatha, Raveendran Nair Sobha Ayswarya, Sreeharshan Sreeja

Open access · greenAbstract readReview
In one paragraph

Review in American journal of cancer research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. The HIV Reservoir and Immune Landscape Across the Life Course of Women: Implications for Cure Strategies.American journal of reproductive immunology (New York, N.Y. : 1989) · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Juberiya M AzeezCancer Research Program, Rajiv Gandhi Centre for Biotechnology Thiruvananthapuram, India.
Thachapillil Ramakrishnan SusmiCancer Research Program, Rajiv Gandhi Centre for Biotechnology Thiruvananthapuram, India.
Viji RemadeviCancer Research Program, Rajiv Gandhi Centre for Biotechnology Thiruvananthapuram, India.
Vini RavindranCancer Research Program, Rajiv Gandhi Centre for Biotechnology Thiruvananthapuram, India.
Anjana Sasikumar SujathaCancer Research Program, Rajiv Gandhi Centre for Biotechnology Thiruvananthapuram, India.
Raveendran Nair Sobha AyswaryaCancer Research Program, Rajiv Gandhi Centre for Biotechnology Thiruvananthapuram, India.
Sreeharshan SreejaCancer Research Program, Rajiv Gandhi Centre for Biotechnology Thiruvananthapuram, India.
Rajiv Gandhi Centre for Biotechnology · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Progesterone, the ovarian steroid hormone, regulates a plentitude of biological processes in tissues ranging from the brain to bones. Recognizing the role of progesterone and its receptors in physiological processes and maladies can prevent and treat various diseases. Apart from its physiological functions, its role in developing diseases, especially breast cancer, is a recent topic of deliberation. There exists conflicting experimental and epidemiological evidence linking progesterone to breast cancer. This review tries to describe the physiological functions of progesterone and its receptors, genomic and non-genomic signaling, splice variants, and a different aspect of progesterone signaling. Furthermore, we seek to address or attempt to discuss the following pertinent questions on steroid hormone signaling; How does progesterone influence breast cancer progression? How does it change the molecular pathways in breast cancer with different receptor statuses, the specific role of each isoform, and how does the ER/and PR ratio affect progesterone signaling?

Indexed as

cancerphysiological functionsProgesteroneprogesterone receptor

Identifiers

PMID34873457
PMCPMC8640821
OpenAlexW4206850251

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.